Testing a new breathing-drug ingredient in healthy adults
Part of Heart & circulation clinical trials.
This early study (Phase 1) tests how safe and tolerable Fx-5A is, and how the body processes it, in healthy volunteers. It’s mainly looking to understand side effects and drug levels rather than treating a disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- If you can become pregnant, use birth control as required during the study and for a short time after the infusion
- Be willing to return for all visits, complete study tasks, and not join other research studies during the study period
- Be able to sign written informed consent
- You must not be pregnant, planning pregnancy during the study, or breastfeeding
- Must not have egg allergies, and must not have known reactions to the Fx-5A ingredients
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.
This first-in-human study tests an experimental drug (FXR0906) in healthy adults to see how safe it is and how the body processes it. The drug may one day help lower high triglycerides (fats in the blood).
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This Phase 1 study tests whether XFB19 is safe and tolerable in healthy adults and how the drug moves through the body (what the blood levels look like). You would be in the study to help researchers understand early safety and dosing information.
Hear when a new Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.